The proposed amendments detailed several areas in regulating of recreational cannabis in the US territory.
Earlier this week, the Cannabis Advisory Board accepted a set of proposed regulations for the recently approved recreational cannabis law in the US Virgin Islands (1). The approval marks a step towards the governing and regulating of recreational cannabis use. “We have been waiting a very long time for this,” Catherine Kean, chairperson for the advisory board (1). The vote was unanimous (2). The public will soon have the option to express their opinions on the 66 pages of rules in a 30-day comment period (1).
Last year, Act 8680, which outlined legalizing cannabis for recreational and sacramental uses, was approved, but its enactment was stalled for various reasons (1,2). People ages 21 and older will be allowed possession of two ounces of cannabis or half an ounce of concentrate for non-medical uses (3).
Cannabis for medicinal uses was approved in 2019 (1). Patients are able to possess a maximum of four ounces of cannabis, two ounce of products, or one ounce of cannabis concentrate (1). Practitioners are now able to register online to qualify for recommending cannabis to patients (2).
A list of people potentially qualified for an expungement of past charges of cannabis possession will soon be submitted for board approval (1). Reportedly, an estimated 300 people have been convicted in the past 20 years (2). “It is my goal to make sure many of us who have been negatively impacted by the criminalization of cannabis are afforded every opportunity to participate in this new and legal cannabis industry,” stated Governor Albert Bryan Jr. after the law was first approved (3).
More developments are anticipated soon: the Office of Cannabis Regulations will hold “fireside chat” meetings with stakeholders in the industry, applications for cultivating or licenses for dispensaries will open within the year, and the advisory board will meet again in April (2).
References
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.